
ALT This image contains an excerpt from the Research Summary “Rivaroxaban Then Aspirin vs. Aspirin Alone after Hip or Knee Arthroplasty” published in the New England Journal of Medicine. It includes diagrams of total arthroplasty for knees and hips, and a cross-section illustrating venous thromboembolism. Below, there are details about the two treatment groups: "Aspirin Alone" with 81 mg daily, and "Rivaroxaban–Aspirin" with 10 mg rivaroxaban for 5 days, followed by 81 mg aspirin daily. Aspirin images accompany each regimen, with N=2718 for Aspirin Alone and N=2647 for rivaroxaban–aspirin. A prompt to read the full Research Summary at NEJM.org sits at the bottom.

ALT A diagram with four quadrants categorizing risk factors based on baseline bleeding and wound-complication risk (y-axis) and baseline VTE risk (x-axis). - Top left: "Standard VTE risk, high bleeding risk," suggesting "Favors Aspirin." - Top right: "High VTE risk, high bleeding risk," advising "Individualize." - Bottom left: "Standard VTE risk, standard bleeding risk," indicating "Aspirin May Be Appropriate." - Bottom right: "High VTE risk, standard bleeding risk," recommending "Favors Anticoagulation." Axes labeled with thresholds as uncertain.
























